Innovation1 Biotech Inc.
IVBT · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 160.8% | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 53.9% | -151% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 40,941.6% | -108,382.7% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 33,766.2% | -218,458.9% |
| EPS Diluted | -0.7 | -2.73 | 5.53 | -8.59 |
| % Growth | 74.4% | -149.4% | 164.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |